Which medicinal cannabis products are affected by the revision of the Act?

All medicinal products containing THC which are exempt from authorisation (i.e. magistral preparations) and finished medicinal products which are authorised and prescribed off-label (i.e. in an indication or dosage form other than that for which they are authorised). These are now no longer prohibited.

There are no changes with regard to medicinal cannabis products which have been authorised by Swissmedic and are prescribed in accordance with the authorised indication and dosage form, e.g. Sativex® (on-label). These were already legal prior to the revision of the Act.